The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / A Transition to 90% Telemedicine: Q&A with Karim Masri, MD

A Transition to 90% Telemedicine: Q&A with Karim Masri, MD

April 9, 2020 • By Susan Bernstein

  • Tweet
  • Email
Print-Friendly Version / Save PDF

How are COVID-19 and current restrictions on physical distancing affecting rheumatologists? The Rheumatologist interviewed Karim Masri, MD, to ask how the pandemic has changed the way he and his clinic staff deliver patient care, and how these unprecedented times affect patients, staff and life outside the office.

You Might Also Like
  • Mobilizing a Long-Term Telemedicine Solution: Q&A with Karen Ferguson
  • The Personal Side of COVID-19: Q&A with Philip A. Waller, MD
  • New Recommendations Support Effective Use of Telemedicine in Primary Care
Also By This Author
  • Diversity: From Concepts to Outcomes

Dr. Masri is a practicing rheumatologist at Bon Secours Rheumatology Center, Richmond, Va. He earned his medical degree at the American University of Beirut, Lebanon. He completed his internal medicine residency at the University of Kansas School of Medicine, Wichita, followed by a rheumatology fellowship at the Johns Hopkins University School of Medicine, Baltimore.

Karim Masri, MD

Q: How are you and your staff adapting to the sudden changes brought about by the pandemic?
It was difficult initially. As the shockwave of the pandemic became real and the mandate that we have to avoid each other to minimize spread, our acceptance of what needs to be done and implementing it happened rapidly. Staff have recruited their families to help with childcare while they are at work. Puppies still go to playgroup.

Q: What types of appointments are you conducting?
We’ve transitioned to telemedicine almost 90%, either via Doxy.me or Epic MyChart, or by telephone calls if patients do not have access to telemedicine technology. New patients are still being seen in person for first-time visits according to the providers’ choice. We are not changing or adjusting any patients’ immunosuppression treatments. We are prescribing as normal.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Q: What are you telling patients about COVID-19’s potential risks and symptoms? What are their chief concerns?
We are telling our patients not to withhold their immunosuppressive treatments, so they minimize their risk of a flare. A flare would require taking prednisone, which is worse than their immunosuppressive therapy when it comes to infection risk. We are counseling [contact] avoidance with social distancing and remaining home, if possible. This is allergy season, so we are disseminating education on the differences between allergies and viral infections. Patients are able to get access to care via telemedicine. Lab testing is also being ordered for patients preferring telemedicine.

Q: How is this affecting you and your staff personally?
I do not speak on behalf of my staff or my employer, Bon Secours Mercy Health (BSMH), but the risk of furlough was the biggest concern for staff due to BMSH reporting last week. But thankfully, it has not affected staffing in our clinic yet. Frustration weighs heavy during this time financially, because some staff do not have savings to rely on, while others have savings locked in the market.

Pages: 1 2 | Single Page

Filed Under: Practice Management Tagged With: coronavirus, COVID-19, telemedicine

You Might Also Like:
  • Mobilizing a Long-Term Telemedicine Solution: Q&A with Karen Ferguson
  • The Personal Side of COVID-19: Q&A with Philip A. Waller, MD
  • New Recommendations Support Effective Use of Telemedicine in Primary Care
  • Finding Opportunity Through Challenge: Q&A with Vaneet K. Sandhu, MD, FACR, RhMSUS

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.